Clinical Trials Browser

UNKNOWN × Interventional × Breast Neoplasms × Clear all

Breast Neoplasms

NCT05287308 2022-03-31

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Phase NA Not yet recruiting

500 enrolled

Breast

Breast Neoplasms

NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Phase 4 Unknown

70 enrolled

Breast

Breast Neoplasms

NCT04646564 2022-01-11

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Phase 3 Recruiting

170 enrolled

Breast

Breast Neoplasms

NCT05045287 2021-09-16

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Phase NA Unknown

57 enrolled

Breast

Breast Neoplasms

NCT01150513 2021-02-09

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Phase 2/3 Completed

320 enrolled

Breast

Breast Neoplasms

NCT03535961 2020-12-02

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Phase 2 Completed

32 enrolled

Breast

Breast Neoplasms

NCT04002284 2020-07-29

Anlotinib in Metastatic HER2 Negative Breast Cancer

Phase 2 Completed

26 enrolled

Breast

Breast Neoplasms

NCT01917279 2020-07-23

CAMELLIA

Phase 3 Unknown

280 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT03461588 2020-03-25

Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer

Phase NA Completed

140 enrolled

Breast

Breast Neoplasms, Heart Injuries, Radiation Injuries

NCT04194684 2019-12-11

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Phase 2 Unknown

108 enrolled

Breast

Breast Neoplasms

NCT04033172 2019-07-25

Pyrotinib

Phase 2 Unknown

40 enrolled

Breast

Breast Neoplasms

NCT02768415 2019-06-19

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Phase 2 Unknown

40 enrolled

Breast

Breast Neoplasms

NCT03933982 2019-05-29

Pyrotinib

Phase 2 Unknown

30 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT03923166 2019-04-22

Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer

Phase 2 Unknown

35 enrolled

Breast

Breast Neoplasms

NCT03923179 2019-04-22

Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer

Phase 2 Unknown

32 enrolled

Breast

Breast Neoplasms

NCT03320421 2019-01-31

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Phase NA Completed

90 enrolled

Breast

Breast Neoplasms

NCT03735082 2018-11-08

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Phase 2 Unknown

29 enrolled

Breast

Breast Neoplasms

NCT00793962 2018-10-11

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

Phase 3 Completed

810 enrolled

Breast

Breast Neoplasms

NCT02646735 2017-01-02

FRIEND

Phase 2 Unknown

148 enrolled

Breast

Breast Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Phase 2 Unknown

230 enrolled

Breast

Breast Neoplasms

NCT00805597 2016-08-08

Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

Phase 3 Terminated

40 enrolled

Breast

Breast Neoplasms

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase 2 Unknown

120 enrolled

Breast

Breast Neoplasms

NCT02460744 2015-06-02

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Phase 2 Completed

50 enrolled

Breast

Breast Neoplasms

NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Phase 2 Unknown

33 enrolled 5 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Phase 2 Unknown

200 enrolled

Breast

Breast Neoplasms

NCT01492556 2013-03-15

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Phase 2 Unknown

100 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT01431053 2013-03-13

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Phase 2 Unknown

160 enrolled

Breast

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Phase 3 Unknown

100 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Phase 3 Unknown

200 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

NCT01278810 2011-01-28

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

Phase 1 Unknown

30 enrolled

Breast

Breast Neoplasms

Clinical Trials

HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Anlotinib in Metastatic HER2 Negative Breast Cancer

CAMELLIA

Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Pyrotinib

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Pyrotinib

Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer

Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

FRIEND

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients